Analysts at B. Riley dropped their Q2 2025 earnings per share estimates for Denali Therapeutics in a research note issued to investors on Wednesday, March 5th. B. Riley analyst M. Mamtani now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback